Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Infectious Disease
•
Neurology
•
Neuromuscular
Do patients on eculizumab or ravulizumab require repeat vaccination against meningococcal infection after a certain interval?
Answer from: at Academic Institution
Yes, CDC recommends a booster Men B vaccine 1 year after completion of series and then every 2-3 years thereafter, and booster Men C every 5 years.
Sign In
or
Register
to read more
16983
Related Questions
How can I incorporate neuromuscular ultrasound into my practice with limited prior experience?
How do you identify patients with false positive AcHR antibodies?
What leads you to suspect that a foot drop is secondary to a myopathy rather than a neuropathic process?
How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?
How do you counsel patients and doctors on antibiotic avoidance in myasthenia gravis?
What types of cardiac conduction abnormalities would lead you to avoid using tricyclic antidepressants?
How do you use total IgG levels, if at all, to guide plasma exchange for myasthenia gravis exacerbations?
How long would you continue chronic transfusion therapy for adult sickle cell patients who have had a stroke?
How would you manage a patient with necrotizing pneumonia due to a susceptible Pseudomonas aeruginosa strain who continues to have significant purulent secretions and worsening imaging while receiving cefepime?
How do you interpret CSF pleocytosis in the context of significant leukocytosis on CBC?